[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.129.96. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
June 5, 1996

Clarification.

JAMA. 1996;275(21):1638. doi:10.1001/jama.1996.03530450028027

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

—In the Medical News & Perspectives article entitled "FDA Gives Calcium Channel Blockers Clean Bill of Health but Warns of Short-Acting Nifedipine Hazards," published in the February 14, 1996, issue of THE JOURNAL (1996;275:423-424), information regarding the meta-analysis by Robert Makuch, PhD, should be clarified. On page 423, right-hand column, first paragraph, eighth line, the sentence should read: "The other meta-analysis, which focused on verapamil alone, showed that in postmyocardial infarction patients there was no evidence of harm with respect to mortality and a suggestion of benefit with respect to nonfatal reinfarctions."

×